https://doi.org/10.1186/2050-6511-14-s1-p5
R
Reiner Frey
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
1.4K
Citations
17
h-index
29
i10-index
Reiner Frey is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Pulmonary Hypertension Research and Treatments & Heart Failure Treatment and Management & Nitric Oxide and Endothelin Effects. The author has an h-index of 17, co-authored 54 publications.
Papers by this author
worksPharmacokinetic interaction of ketoconazole, clarithromycin, and midazolam with riociguat
2013 · BMC Pharmacology and Toxicology · 9 citations
Effects of omeprazole and AlOH/MgOH on riociguat absorption
2013 · BMC Pharmacology and Toxicology · 3 citations
https://doi.org/10.1186/2050-6511-14-s1-p6
Bioavailability, pharmacokinetics and safety of riociguat given as an oral suspension or crushed tablet with and without food
2015 · BMC Pharmacology and Toxicology · 2 citations
https://doi.org/10.1186/2050-6511-16-s1-a82
Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls
2011 · BMC Pharmacology · 0 citations
https://doi.org/10.1186/1471-2210-11-s1-p61
Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
2011 · BMC Pharmacology · 0 citations
https://doi.org/10.1186/1471-2210-11-s1-p26
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat